Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15516961 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Dichloroacetate (DCA) in Patients With Previously Treated Metastatic Breast or Non-Small Cell Lung Cancer (NSCL)
Conditions: Metastatic Breast Cancer;   Lung Cancer
Intervention: Drug: Herceptin plus DCA

Indicates status has not been verified in more than two years